Default options in advance directives: study protocol for a randomised clinical trial

Por Gabler, Nicole B, Cooney, Elizabeth, Small, Dylan S, Troxel, Andrea B, Arnold, Robert M, White, Douglas B, Angus, Derek C, Loewenstein, George, Volpp, Kevin G, Bryce, Cindy L, Halpern, Scott D
Publicado no BMJ Open (2016)

Angiogenesis inhibition as a therapeutic strategy in non-small cell lung cancer (NSCLC)

Por Hall, Richard D., Le, Tri M., Haggstrom, Daniel E., Gentzler, Ryan D.
Publicado no Transl Lung Cancer Res (2015)

Analysis by sex of low back pain among workers from small companies in the Paris area: severity and occupational consequences

Por Alcouffe, J., Manillier, P., Brehier, M., Fabin, C., Faupin, F.
Publicado em 1999

Urine test for EGFR analysis in patients with non-small cell lung cancer

Por Franovic, Aleksandra, Raymond, Victoria M., Erlander, Mark G., Reckamp, Karen L.
Publicado no J Thorac Dis (2017)

Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC): contemporary insights and advances

Por Sebastian, Nikhil T., Xu-Welliver, Meng, Williams, Terence M.
Publicado no J Thorac Dis (2018)

Programmed cell death ligand-1 (PD-L1) as a biomarker for non-small cell lung cancer (NSCLC) treatment—are we barking up the wrong tree?

Por Dempke, Wolfram C. M., Fenchel, Klaus, Dale, Stephen P.
Publicado no Transl Lung Cancer Res (2018)

Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.

Por Brown, T, Pilkington, G, Bagust, A, Boland, A, Oyee, J, Tudur-Smith, C, Blundell, M, Lai, M, Martin Saborido, C, Greenhalgh, J, Dundar, Y, Dickson, R
Publicado no Health Technol Assess (2013)

Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation

Por T Brown, G Pilkington, A Bagust, A Boland, J Oyee, C Tudur Smith, M Blundell, M Lai, C Martin Saborido, J Greenhalgh, Y Dundar, R Dickson
Publicado em 2013-07-01

Case series of treatment approaches in fit nonagenarians with stage IV non-small-cell lung cancer

Por Britt, Gregory J, Gaughan, Elizabeth M, Nguyen, Kim-Son H, Warner, Jeremy L, Goldstein, Michael A, Huberman, Mark S, Costa, Daniel B
Publicado em 2011

Population attributable risk estimates for factors associated with non-use of postnatal care services among women in Nigeria

Por Agho, K E, Ezeh, O K, Issaka, A I, Enoma, A I, Baines, S, Renzaho, A M N
Publicado no BMJ Open (2016)

Validation of an algorithm to determine the primary care treatability of emergency department visits

Por Jeffery, Molly Moore, Bellolio, M Fernanda, Wolfson, Julian, Abraham, Jean M, Dowd, Bryan E, Kane, Robert L
Publicado no BMJ Open (2016)

Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group

Por Dietel, Manfred, Bubendorf, Lukas, Dingemans, Anne-Marie C, Dooms, Christophe, Elmberger, Göran, García, Rosa Calero, Kerr, Keith M, Lim, Eric, López-Ríos, Fernando, Thunnissen, Erik, Van Schil, Paul E, von Laffert, Maximilian
Publicado no Thorax (2016)

Impact analysis studies of clinical prediction rules relevant to primary care: a systematic review

Por Wallace, Emma, Uijen, Maike J M, Clyne, Barbara, Zarabzadeh, Atieh, Keogh, Claire, Galvin, Rose, Smith, Susan M, Fahey, Tom
Publicado no BMJ Open (2016)

Liquid biopsy for ctDNA to revolutionize the care of patients with early stage lung cancers

Por Li, Bob T., Stephens, Dennis, Chaft, Jamie E., Rudin, Charles M., Jones, David R., Rusch, Valerie W., Rimner, Andreas, Isbell, James M.
Publicado no Ann Transl Med (2017)

Polymyxin B-immobilised haemoperfusion and mortality in critically ill patients with sepsis/septic shock: a protocol for a systematic review and meta-analysis

Por Fujii, Tomoko, Ganeko, Riki, Kataoka, Yuki, Featherstone, Robin, Bagshaw, Sean M, Furukawa, Toshi A
Publicado no BMJ Open (2016)

Multicentre, open-label, randomised, parallel-group, superiority study to compare the efficacy of octreotide therapy 40 mg monthly versus standard of care in patients with refractory anaemia due to gastrointestinal bleeding from small bowel angiodysplasias: a protocol of the OCEAN trial

Por Grooteman, K V, van Geenen, E J M, Drenth, J P H
Publicado no BMJ Open (2016)

What causes a small increase in radiographic progression in rheumatoid arthritis patients tapering TNF inhibitors?

Por Bouman, Chantal A M, den Broeder, Alfons A, van der Maas, Aatke, van den Hoogen, Frank H J, Landewé, Robert B M, van Herwaarden, Noortje
Publicado no RMD Open (2017)

Effective components of nurse-coordinated care to prevent recurrent coronary events: a systematic review and meta-analysis

Por Snaterse, Marjolein, Dobber, Jos, Jepma, Patricia, Peters, Ron J G, ter Riet, Gerben, Boekholdt, S Matthijs, Buurman, Bianca M, Scholte op Reimer, Wilma J M
Publicado no Heart (2016)

Aggregated N-of-1 trials for unlicensed medicines for small populations: an assessment of a trial with ephedrine for myasthenia gravis

Por Stephanie S. Weinreich, Charlotte Vrinten, Marja R. Kuijpers, Alexander F. Lipka, Kirsten J. M. Schimmel, Erik W. van Zwet, Christine Gispen-de Wied, Yechiel A. Hekster, Jan J. G. M. Verschuuren, Martina C. Cornel
Publicado em 2017-05-01

Aggregated N-of-1 trials for unlicensed medicines for small populations: an assessment of a trial with ephedrine for myasthenia gravis

Por Weinreich, Stephanie S., Vrinten, Charlotte, Kuijpers, Marja R., Lipka, Alexander F., Schimmel, Kirsten J. M., van Zwet, Erik W., Gispen-de Wied, Christine, Hekster, Yechiel A., Verschuuren, Jan J. G. M., Cornel, Martina C.
Publicado no Orphanet J Rare Dis (2017)